BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6285173)

  • 21. Regulation by neurohormones of cyclic AMP concentration in cells derived from the nervous system.
    Hamprecht B; Brandt M; Propst F; van Calker D; Löffler F
    Adv Cyclic Nucleotide Res; 1981; 14():637-45. PubMed ID: 6269404
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of exposure to unsaturated fatty acids on opiate receptors, prostaglandin E1 receptors, and adenylate cyclase activity of neuroblastoma x glioma hybrid cells.
    McGee R; Kenimer JG
    Mol Pharmacol; 1982 Sep; 22(2):360-8. PubMed ID: 6292694
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of opiate receptor-adenylate cyclase interactions by calcium ions and guanosine-5'-triphosphate.
    Wilkening D; Sabol SL; Nirenberg M
    Brain Res; 1980 May; 189(2):459-66. PubMed ID: 6245765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The opioid-induced desensitization (tolerance) in neuroblastoma x glioma NG 108-15 hybrid cells: results from receptor uncoupling.
    Wüster M; Costa T
    NIDA Res Monogr; 1984; 54():136-45. PubMed ID: 6099870
    [No Abstract]   [Full Text] [Related]  

  • 25. On the mechanism of receptor-mediated inhibition of adenylate cyclase.
    Klee WA; Koski G; Tocque B; Simonds WF
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():153-9. PubMed ID: 6145318
    [No Abstract]   [Full Text] [Related]  

  • 26. Heterologous up-regulation of Ni-coupled receptors in cultured neural hybrid cells by a transferable factor, whose expression is inhibited in a cyclic AMP-dependent, cell-specific manner.
    Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
    Mol Pharmacol; 1987 Nov; 32(5):669-77. PubMed ID: 2824982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-free desensitization of opioid inhibition of adenylate cyclase in neuroblastoma X glioma NG108-15 hybrid cell membranes.
    Louie AK; Law PY; Loh HH
    J Neurochem; 1986 Sep; 47(3):733-7. PubMed ID: 3016185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of multiple cellular adaptation processes in clonal cell lines during chronic opiate treatment.
    Law PY; Griffin MT; Loh HH
    NIDA Res Monogr; 1984; 54():119-35. PubMed ID: 6099869
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of an adenylate cyclase-linked serotonin (5-HT) receptor system in a neuroblastoma x brain explant hybrid cell line (NCB-20) by opiates, prostaglandins, and alpha 2-adrenergic agonists.
    Berry-Kravis E; Dawson G
    Adv Biochem Psychopharmacol; 1983; 37():361-72. PubMed ID: 6138954
    [No Abstract]   [Full Text] [Related]  

  • 30. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
    Carter BD; Medzihradsky F
    Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of GTP and cations on binding of labeled dimeric and monomeric enkephalins to neuroblastoma-glioma cell delta opiate receptors.
    Krumins SA; Costa T; Shimohigashi Y; Munson PJ; Rodbard D
    Biochem Biophys Res Commun; 1982 Sep; 108(1):406-13. PubMed ID: 6293490
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of phospholipases on chronic opiate action in neuroblastoma X glioma NG108-15 hybrid cells.
    Griffin MT; Law PY; Loh HH
    J Neurochem; 1986 Oct; 47(4):1098-105. PubMed ID: 3018158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute & chronic opiate action in NG108-15 hybrid cells cultured in serum-free medium.
    Griffin MT; Law PY; Loh HH
    Proc West Pharmacol Soc; 1984; 27():561-4. PubMed ID: 6541790
    [No Abstract]   [Full Text] [Related]  

  • 34. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of adenylate cyclase of neuroblastoma x glioma hybrid cells by alpha-adrenergic receptors. I. Inhibition of adenylate cyclase mediated by alpha receptors.
    Sabol SL; Nirenberg M
    J Biol Chem; 1979 Mar; 254(6):1913-20. PubMed ID: 33989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-Endorphin. Opiate receptor-binding activity of synthetic analogs modified in the enkephalin segment in rat brain membrane and neuroblastoma x glioma hybrid cell.
    Hammonds RG; Li CH
    Int J Pept Protein Res; 1982 Mar; 19(3):254-8. PubMed ID: 6288587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of adenyl cyclase in opiate tolerance and dependence.
    Klee WA; Milligan G; Simonds WF; Tocque B
    NIDA Res Monogr; 1984; 54():109-18. PubMed ID: 6152484
    [No Abstract]   [Full Text] [Related]  

  • 39. Uncoupling of receptors is essential for opiate-induced desensitization (tolerance) in neuroblastoma x glioma hybrid cells NG 108-15.
    Wüster M; Costa T; Gramsch C
    Life Sci; 1983; 33 Suppl 1():341-4. PubMed ID: 6319890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycolipids and opiate action.
    McLawhon RW; Schoon GS; Dawson G
    Eur J Cell Biol; 1981 Oct; 25(2):353-8. PubMed ID: 6277638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.